[1]
S. . Abbasi, H. . Dwaik, L. . Abbasi, and H. Al Hourani, “A pilot study of activity of pembrolizumab and low dose chemotherapy in relapsed/refractory T-cell lymphoma: Jordanian experience”, Acta Biomed, vol. 95, no. 5, p. e2024102, Oct. 2024, doi: 10.23750/abm.v95i5.15559.